|
Coronary heart disease
|
|
0.050 |
GeneticVariation
|
BEFREE |
Contribution of coagulation factor VII R353Q, -323P0/10 and HVR4 polymorphisms to coronary artery disease in Tunisians.
|
22932775 |
2013 |
|
Coronary heart disease
|
|
0.050 |
GeneticVariation
|
BEFREE |
The -323Ins10 polymorphism in factor VII gene is significantly associated with CHD in both Asian and European populations, while R353Q polymorphism showed trend for association with CHD in Asians.
|
21838885 |
2011 |
|
Coronary heart disease
|
|
0.050 |
GeneticVariation
|
BEFREE |
The influence of functional polymorphisms in the FVII gene (-670A>C, -402G>A, -401G>T and R353Q) and of established cardiovascular risk factors on plasma concentrations of FVII were investigated in a representative sample of middle-aged women with (n=238) and without (n=220) coronary heart disease (CHD).
|
15711754 |
2005 |
|
Coronary heart disease
|
|
0.050 |
GeneticVariation
|
BEFREE |
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
|
15081566 |
2004 |
|
Coronary heart disease
|
|
0.050 |
GeneticVariation
|
BEFREE |
Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
|
10803689 |
2000 |
|
Coronary Artery Disease
|
|
0.030 |
GeneticVariation
|
BEFREE |
Contribution of coagulation factor VII R353Q, -323P0/10 and HVR4 polymorphisms to coronary artery disease in Tunisians.
|
22932775 |
2013 |
|
Coronary Arteriosclerosis
|
|
0.030 |
GeneticVariation
|
BEFREE |
Contribution of coagulation factor VII R353Q, -323P0/10 and HVR4 polymorphisms to coronary artery disease in Tunisians.
|
22932775 |
2013 |
|
Myocardial Infarction
|
|
0.030 |
GeneticVariation
|
BEFREE |
The presence of the Gln allele in the Arg353Gln polymorphism in the FVII locus did not differ between patients and control individuals but was associated with lower plasma levels of FVIIag and FVIIa that could have a protective effect against myocardial infarction.
|
17581323 |
2007 |
|
Coronary Arteriosclerosis
|
|
0.030 |
GeneticVariation
|
BEFREE |
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
|
15081566 |
2004 |
|
Coronary Artery Disease
|
|
0.030 |
GeneticVariation
|
BEFREE |
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
|
15081566 |
2004 |
|
Myocardial Infarction
|
|
0.030 |
GeneticVariation
|
BEFREE |
No significant associations between the R353Q polymorphism and MI, CVD, or diabetes were observed, although the polymorphism strongly influenced plasma levels of FVII.
|
15081566 |
2004 |
|
Myocardial Infarction
|
|
0.030 |
GeneticVariation
|
BEFREE |
In order to determine the role of two polymorphisms in the factor VII gene (R353Q and intron 7 hypervariable region) in the susceptibility to develop early myocardial infarction, a total of 175 patients with acute myocardial infarction aged 50 years or less (mean age 41+/-7 years) and 200 controls (average age 42+/-6) without cardiovascular disease were genotyped for these polymorphisms.
|
11578716 |
2001 |
|
Coronary Arteriosclerosis
|
|
0.030 |
GeneticVariation
|
BEFREE |
Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
|
10803689 |
2000 |
|
Coronary Artery Disease
|
|
0.030 |
GeneticVariation
|
BEFREE |
In conclusion, the 4G/5G PAI-1 promoter polymorphism and Arg353-->Gln FVII polymorphism are not major genetic risk factors for CAD in Koreans.
|
10803689 |
2000 |
|
Cardiovascular Diseases
|
|
0.020 |
GeneticVariation
|
BEFREE |
To examine the R353Q polymorphism of the FVII gene and the relation to myocardial infarction (MI), cardiovascular disease (CVD), and diabetes, and furthermore, to elucidate the association between the polymorphism and plasma levels of FVII coagulant activity (FVIIc), FVII antigen (FVIIag), activated FVII (FVIIa), and serum choline-containing phospholipids (PC).
|
15081566 |
2004 |
|
Acute myocardial infarction
|
|
0.020 |
GeneticVariation
|
BEFREE |
Associations of the known polymorphisms of the coagulation factor VII (FVII) gene (R353Q), the coagulation factor XIII (FXIII) gene (V34L) and the glycoprotein Ia (Gp1a) gene (C807T) with the occurrence of AMI were studied in 142 AMI survivors and 142 age- and sex-matched control subjects.
|
12486862 |
2002 |
|
Cardiovascular Diseases
|
|
0.020 |
GeneticVariation
|
BEFREE |
In order to determine the role of two polymorphisms in the factor VII gene (R353Q and intron 7 hypervariable region) in the susceptibility to develop early myocardial infarction, a total of 175 patients with acute myocardial infarction aged 50 years or less (mean age 41+/-7 years) and 200 controls (average age 42+/-6) without cardiovascular disease were genotyped for these polymorphisms.
|
11578716 |
2001 |
|
Acute myocardial infarction
|
|
0.020 |
GeneticVariation
|
BEFREE |
In order to determine the role of two polymorphisms in the factor VII gene (R353Q and intron 7 hypervariable region) in the susceptibility to develop early myocardial infarction, a total of 175 patients with acute myocardial infarction aged 50 years or less (mean age 41+/-7 years) and 200 controls (average age 42+/-6) without cardiovascular disease were genotyped for these polymorphisms.
|
11578716 |
2001 |
|
Thrombosis of cerebral veins
|
|
0.010 |
GeneticVariation
|
BEFREE |
Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis.
|
22136731 |
2012 |
|
Vertical Talus
|
|
0.010 |
GeneticVariation
|
BEFREE |
Our findings suggest that the FVII R353Q polymorphism is not associated with increased risk for CVT occurring during the puerperal period in Indian women.
|
22136731 |
2012 |
|
Diabetes Mellitus
|
|
0.010 |
GeneticVariation
|
BEFREE |
To examine the R353Q polymorphism of the FVII gene and the relation to myocardial infarction (MI), cardiovascular disease (CVD), and diabetes, and furthermore, to elucidate the association between the polymorphism and plasma levels of FVII coagulant activity (FVIIc), FVII antigen (FVIIag), activated FVII (FVIIa), and serum choline-containing phospholipids (PC).
|
15081566 |
2004 |
|
Diabetes
|
|
0.010 |
GeneticVariation
|
BEFREE |
To examine the R353Q polymorphism of the FVII gene and the relation to myocardial infarction (MI), cardiovascular disease (CVD), and diabetes, and furthermore, to elucidate the association between the polymorphism and plasma levels of FVII coagulant activity (FVIIc), FVII antigen (FVIIag), activated FVII (FVIIa), and serum choline-containing phospholipids (PC).
|
15081566 |
2004 |
|
Cerebrovascular accident
|
|
0.010 |
GeneticVariation
|
BEFREE |
Circulating levels of Factor VII:C are determined by R353Q genotype and cluster with other risk factors associated with insulin resistance in South Asian ischaemic stroke patients, first-degree relatives and control subjects but are not related to stroke or a family history of stroke.
|
12529745 |
2002 |